Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
Did you mean: ()?
72 results
  • Targeting BTK in CLL: Beyond Ibrutinib. [Review]
  • CHCurr Hematol Malig Rep 2019; 14(3):197-205
  • Bond DA, Woyach JA
  • While the Bruton's tyrosine kinase inhibitor (BTKi) ibrutinib has revolutionized the treatment of chronic lymphocytic leukemia (CLL), current limitations include off-target toxicities and the develop…
  • Acalabrutinib for mantle cell lymphoma. [Review]
  • BloodBlood 2019 Jun 13; 133(24):2570-2574
  • Witzig TE, Inwards D
  • Mantle cell lymphoma (MCL) is a unique type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1. MCL patients typically live for years but experience multiple relapses. Acalabrut…
New Search Next